Global Topical Drug Delivery Market Research Report
- Report Code: TO 1000
- Publish Date: Upcoming
The global topical drug delivery market, mainly driven by patent cliffs, increased incidence of chronic diseases, increasing competition, improving patient compliance, and huge investments made by key pharmaceutical companies, was valued at $9.44 billion in 2013, and expected to reach $11.21 billion by 2018, at a CAGR of 3.50%.
The report ‘Global Topical Drug Delivery Market forecast, 2012-2018’ analyzes the market by segments, such as semi-solid formulations, liquid formulations, and solid formulations.
North America is a hub for a large number of pharmaceutical companies and drug delivery technology providers. The U.S. is the world’s largest pharmaceuticals market, and is the world leader in biopharmaceutical research, with 80.00% of the world’s research and development in the biotechnology sector being conducted by the firms in this region. According to the Bureau of Labor Statistics (U.S.), the pharmaceutical sector employed approximately 272,000 people, and spent $67.40 billion on research and development in 2010. Thus, the well-established U.S. pharmaceutical industry is a favorable factor for the growth of the overall drug delivery market, and consequently for the topical drug delivery market as well.
The key drivers for the drug delivery market in North America are the robust pharmaceutical industry, presence of large number of pharmaceutical companies and drug delivery technology providers, and increasing number of collaborations & partnerships between technology providers & pharmaceutical companies. In addition, an increased demand for self-administration and home healthcare devices, and increasing applications of inhalers, transdermal patches, and topical systems for chronic disease areas such as migraine, diabetes, cancer pain, and asthma have also boosted the growth of this market.
Europe holds the second position in the overall pharmaceutical market. The European pharmaceutical market was worth $228.00 billion in 2011, accounting to 26.80% of the global pharmaceuticals market. The industry invested Euro 27,500.00 million in R&D in 2011, provided direct employment to 660,000 Europeans, and generated three to four times more employment indirectly. The pharmaceutical markets in the major five European countries - Germany, France, the U.K., Italy, and Spain - grew at an average rate of 2.60% in 2011, which is a driving factor for the concerned market in this region.
Asia held a share of 15.00% in the total drug delivery market in 2012, and was worth $21.71 billion. It is poised to grow at a CAGR of 12.60%, to reach $39.35 billion by 2017. The major factors propelling the Asian market are saturated the western markets. Furthermore, expansion of the Asian economy, increase in disposable income, development of healthcare infrastructure, and increasing awareness for health insurance will further boost the growth of the pharmaceutical market. This, in turn, will accelerate the growth of the topical drug delivery market in Asia.
The report also provides an extensive competitive landscaping of companies operating in this market. The major companies operating in the topical drug delivery market are Galderma S.A., Stiefel Laboratories, Inc., and Valeant Pharmaceuticals International, Inc.
Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options
Along with the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Pharmacists Forum
- Fast turn-around analysis of pharmacists’ response to market events and trends
- Pharmacists’ opinion about products from different companies
- Pharmacists’ qualitative inputs on epidemiology data
- Pattern analysis of usage of drugs by physicians
Brand/Product Perception Matrix
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Semi-Solid Formulations Semi-Solid Formulations and Liquid Formulations and Solid... |
Upcoming |
|
|
Liquid Formulations Liquid Formulations and Semi-Solid Formulations and |
Upcoming |
|
|
Solid Formulations Solid Formulations and Semi-Solid Formulations and |
Upcoming |
|
|
Asian Topical Drug Delivery Market The Asian Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.54 billion in 2013 and expected to be $2.10 billion by 2018, growing at a CAGR of 6.4%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
|
|
European Topical Drug Delivery Market The European Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.64 billion in 2013 and expected to be $2.96 billion by 2018, growing at a CAGR of 2.3%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
|
|
North American Topical Drug Delivery Market The North American Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.23 billion in 2013 and expected to be $4.90 billion by 2018, growing at a CAGR of 3.0%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc. |
Upcoming |
